TFF Pharmaceuticals Inc. (TFFP)

NASDAQ: TFFP · Real-Time Price · USD

0.07

-0.09 (-56.98%)

At close: Dec 12, 2024, 9:00 PM

TFF Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019
Period Ending	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Net Income	-3.54M	-4.48M	-5.74M	-4.76M	-4.41M	-5.02M	-7.05M	-7.37M	-7.27M	-8.75M	-8.38M	-10.05M	-8.68M	-4.66M	-7.65M	-5.9M	-5.06M	-3.82M	-3.8M	-4.66M	-2.84M	-2.19M	-2.18M
Depreciation & Amortization	141.02K	140.59K	140.18K	130.67K	125.12K	123.53K	123.17K	120.91K	101.14K	89.15K	77.03K	77.03K	28.45K	4.49K	1.5K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	567.67K	608.35K	626.99K	582.43K	766.32K	825.72K	751.82K	923.49K	955.56K	1.2M	1.18M	920.82K	856.59K	740.53K	1.03M	919.83K	546.12K	295.36K	425.84K	211.43K	-229.01K	486.4K	121.23K
Other Working Capital	-2.08M	326.99K	1.02M	441.25K	489.73K	-58.62K	663.21K	-647.37K	546.54K	100K	-317.24K	-1.77M	545.74K	-1.67M	510.3K	-1.62M	28.54K	268.54K	222.73K	312.82K	-246.18K	13.37K	-28.39K
Other Non-Cash Items	2.62M	560.47K	44.27K	391.3K	49K	9.69K	720.63K	-212.15K	2.89M	-284.71K	1.4M	-2.18M	1.41M	1.06M	512.29K	-235.5K	n/a	n/a	n/a	-11.22M	n/a	n/a	n/a
Deferred Income Tax	n/a	n/a	n/a	-920.3K	n/a	n/a	n/a	212.15K	-2.89M	n/a	n/a	2.18M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-1.77M	-83.68K	1.85M	364.71K	468.13K	-396.86K	1.09M	-1.37M	-1.16M	2.45M	-125.03K	-1.83M	601.78K	-1.98M	1.03M	-1.26M	256.17K	-253.41K	1.02M	143.96K	-4.06K	-21.76K	-54.08K
Operating Cash Flow	-1.98M	-3.25M	-3.14M	-4.21M	-3M	-4.46M	-4.37M	-7.7M	-7.38M	-5.01M	-7.25M	-10.88M	-7.19M	-5.89M	-5.59M	-6.23M	-4.26M	-3.77M	-2.35M	-4.31M	-3.07M	-1.72M	-2.12M
Capital Expenditures	-1	1.00	n/a	-46.39K	-12.65K	-35.71K	n/a	-141.17K	-777.48K	-495.45K	-137.23K	-126.65K	-141.64K	-124.08K	-476.13K	-809.57K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	293.24K	-293.24K	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	-46.39K	-12.65K	-35.71K	n/a	-141.17K	-777.48K	-495.45K	-137.23K	-126.65K	-141.64K	-124.08K	-476.13K	-809.57K	-293.24K	n/a	-1.13M	n/a	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-21.73K	-971.28K	888.55K	-2.88K	n/a	-59.23K	-17.92K	11.34M	26.18K	-15.99K	n/a	n/a	n/a	34.5K	835.47K	714.38K	n/a	n/a	n/a	21.85M	n/a	7.21M	n/a
Financial Cash Flow	199.06K	4.42M	901.14K	567.00	5.09M	-59.23K	-17.92K	11.34M	430.74K	-15.99K	n/a	n/a	n/a	25.95K	28.86M	714.38K	24.28M	n/a	1.13M	21.85M	-10.17K	7.21M	n/a
Net Cash Flow	-1.78M	1.18M	-2.27M	-4.25M	2.06M	-4.55M	-4.4M	3.47M	-7.74M	-5.52M	-7.38M	-10.92M	-7.35M	-5.99M	22.75M	-6.32M	19.69M	-3.81M	-2.36M	17.54M	-3.08M	5.49M	-2.12M
Free Cash Flow	-1.98M	-3.25M	-3.14M	-4.26M	-3.01M	-4.49M	-4.37M	-7.84M	-8.16M	-5.51M	-7.38M	-11.01M	-7.33M	-6.01M	-6.07M	-7.04M	-4.26M	-3.77M	-2.35M	-4.31M	-3.07M	-1.72M	-2.12M